Epstein-Barr Virus and Posttransplant Lymphoproliferative Disorder in Solid Organ Transplant Recipients

被引：82
作者：
Allen, U. [1 ]
Preiksaitis, J. [2 ]
机构：
[1] Univ Toronto, Hosp Sick Children, Div Infect Dis, Toronto, ON M5G 1X8, Canada
[2] Univ Alberta, Dept Med, Edmonton, AB, Canada
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2009年 / 9卷
关键词：
B-lymphocyte; cytotoxic T lymphocyte surveillance; Epstein-Barr virus; posttransplant lymphoproliferation; primary infection; PTLD; CYTOTOXIC T-LYMPHOCYTES; EBV DNA LOAD; VIRAL LOAD; PERIPHERAL-BLOOD; DISEASE; RISK; THERAPY; MANAGEMENT; QUANTIFICATION; PREVENTION;
D O I：
10.1111/j.1600-6143.2009.02898.x
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：S87 / S96
页数：10
相关论文
共 61 条
  • [1] Allen UD, 2005, ADV EXP MED BIOL, V568, P25
  • [2] Risk factors for post-transplant lymphoproliferative disorder in pediatric patients:: A case-control study
    Allen, UD
    Farkas, G
    Hébert, D
    Weitzman, S
    Stephens, D
    Petric, M
    Tellier, R
    Ngan, B
    Fecteau, A
    West, L
    Wasfy, S
    [J]. PEDIATRIC TRANSPLANTATION, 2005, 9 (04) : 450 - 455
  • [3] Badley A D, 1996, Liver Transpl Surg, V2, P375, DOI 10.1002/lt.500020508
  • [4] Slc11a1 (formerly Nramp1) polymorphisms and susceptibility to post-transplant lymphoproliferative disease following pediatric liver transplantation
    Barshes, N. R.
    Lee, T. R.
    Goss, J. A.
    Goodpastor, S. E.
    Huls, M. H.
    Rooney, C. M.
    Karpen, S. J.
    Wyllie, S.
    [J]. TRANSPLANT INFECTIOUS DISEASE, 2006, 8 (02) : 108 - 112
  • [5] Clinical usefulness of FDG-PET/CT scan imaging in the management of posttransplant lymphoproliferative disease
    Bianchi, Elena
    Pascual, Manuel
    Nicod, Marie
    Delaloye, Angelika Bischof
    Duchosal, Michel A.
    [J]. TRANSPLANTATION, 2008, 85 (05) : 707 - 712
  • [6] Chronic high Epstein-Barr viral load state and risk for late-onset posttransplant lymphoproliferative disease/lymphoma in children
    Bingler, M. A.
    Feingold, B.
    Miller, S. A.
    Quivers, E.
    Michaels, M. G.
    Green, M.
    Wadowsky, R. M.
    Rowe, D. T.
    Webber, S. A.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 (02) : 442 - 445
  • [7] qRituximab therapy is effective for posttransplant lymphoproliferative disorders after solid organ transplantation - Results of a phase II trial
    Blaes, AH
    Peterson, BA
    Bartlett, N
    Dunn, DL
    Morrison, VA
    [J]. CANCER, 2005, 104 (08) : 1661 - 1667
  • [8] Epstein-Barr virus-specific cytotoxic T-lymphocytes for adoptive immunotherapy of post-transplant lymphoproliferative disease
    Burns, DM
    Crawford, DH
    [J]. BLOOD REVIEWS, 2004, 18 (03) : 193 - 209
  • [9] Posttransplant lymphoproliferative disorders after renal transplantation in the United States in era of modern immunosuppression
    Caillard, S
    Dharnidharka, V
    Agodoa, L
    Bohen, E
    Abbott, K
    [J]. TRANSPLANTATION, 2005, 80 (09) : 1233 - 1243
  • [10] Epstein-Barr virus (EBV) early-antigen serologic testing in conjunction with peripheral blood EBV DNA load as a marker for risk of posttransplantation lymphoproliferative disease
    Carpentier, L
    Tapiero, B
    Alvarez, F
    Viau, C
    Alfieri, C
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2003, 188 (12) : 1853 - 1864
1234567